Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02423213 · ClinicalTrials.gov registry record
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
A clinical trial of Retinal Diseases and Fuchs Endothelial Dystrophy, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT02423213 is a study of Retinal Diseases and Fuchs Endothelial Dystrophy that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 3,000 participants, above the 22-participant average among 8 other Retinal Diseases trials with a reported enrollment target (13536% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02423213, a study of Retinal Diseases and Fuchs Endothelial Dystrophy, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Optical coherence tomography (OCT )provides high resolution information regarding the anatomic structure of the tissues of the eye in a cross-sectional and 3 dimensional view. Much of this information is not able to be visualized by a clinician. Utilizing this information during surgery will allow for the ophthalmic surgeons to better understand how surgical procedures impact the anatomic structure of the eye. In this study an OCT device that has been built into the microscope (rather than mounted on the side or held in the surgeon's hand) and will be utilized to take images at various milestones during surgery to assess feasibility and potential utility of this technology. Since it is built into the microscope, there are potential significant advantages over a separate system including increased efficiency, improved working distance, and the ability to visualize tissue-instrument interactions.
Conditions Studied
Study Locations (1)
Ohio
- Cole Eye Institute, Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02423213
The ClinicalTrials.gov registry entry for NCT02423213 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 22-participant average among 8 other Retinal Diseases trials with a reported enrollment target (13536% higher). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Retinal Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT02423213 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02423213 about?
NCT02423213 is a clinical study titled "DISCOVER Study: Microscope-integrated Intraoperative OCT Study". Optical coherence tomography (OCT )provides high resolution information regarding the anatomic structure of the tissues of the eye in a cross-sectional and 3 dimensional view. Much of this information is not able to be visualized by a clinician. Utilizing this information during surgery will allow f...
What is the current status of trial NCT02423213?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2014-01. Estimated completion is 2027-01.
What conditions does trial NCT02423213 study?
This clinical trial studies the following conditions: Retinal Diseases, Fuchs Endothelial Dystrophy, Epiretinal Membrane, Retinal Detachment, Macular Hole.
Who is sponsoring clinical trial NCT02423213?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02423213 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
RECRUITING · NA
-
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
ACTIVE NOT RECRUITING · Phase 1
-
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
ACTIVE NOT RECRUITING
-
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
COMPLETED · Phase 3
-
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.